Samalin Investment Counsel’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-10,738
| Closed | -$87K | – | 264 |
|
2022
Q3 | $87K | Sell |
10,738
-5,000
| -32% | -$40.5K | 0.06% | 220 |
|
2022
Q2 | $118K | Buy |
15,738
+523
| +3% | +$3.92K | 0.08% | 215 |
|
2022
Q1 | $143K | Sell |
15,215
-3,500
| -19% | -$32.9K | 0.09% | 234 |
|
2021
Q4 | $150K | Buy |
+18,715
| New | +$150K | 0.09% | 242 |
|
2020
Q1 | – | Sell |
-8,105
| Closed | -$79K | – | 473 |
|
2019
Q4 | $79K | Buy |
+8,105
| New | +$79K | 0.07% | 243 |
|